New China Indications For Merck, Novo, Boehringer Drugs

 
• By Brian Yang

China continues with a post-coronavirus approvals rush, granting additional indications to Merck's Keytruda, BI's Ofev and Novo Nordisk's Norditropin.

Red Approved Stamp with Wooden handle Rubber Stamper Isolated on White Background.
China Approves Multiple New Indications • Source: Shutterstock

More from China

More from Asia